{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:32:53Z","timestamp":1790861573288,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.dnarep.2009.10.003","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T15:04:15Z","timestamp":1258556655000},"page":"40-47","source":"Crossref","is-referenced-by-count":37,"title":["Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells"],"prefix":"10.1016","volume":"9","author":[{"given":"Jenifer","family":"Saffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus H.","family":"Agnoletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temenouga N.","family":"Guecheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds F.Z.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helotonio","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.P.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Stary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.M.","family":"Menck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Sarasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dnarep.2009.10.003_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1383-5718(99)00164-3","article-title":"DNA damage and repair: consequences on dose-responses","volume":"364","author":"Moustacchi","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mrfmmm.2004.04.001","article-title":"Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer","volume":"554","author":"Blasiak","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ctrv.2005.09.006","article-title":"The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer","volume":"31","author":"Madhusudan","year":"2005","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.dnarep.2009.10.003_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2005.09.004","article-title":"DNA repair inhibition: a selective tumour targeting strategy","volume":"11","author":"Madhusudan","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.dnarep.2009.10.003_bib5","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.1158\/0008-5472.CAN-07-2964","article-title":"Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks","volume":"67","author":"Batista","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-4781(98)00132-8","article-title":"Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme","volume":"1400","author":"Burden","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.dnarep.2009.10.003_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568011013354723","article-title":"Anthracyclines: selected new developments","volume":"1","author":"Binaschi","year":"2001","journal-title":"Curr. Med. Chem. -Anti-Cancer Agents"},{"key":"10.1016\/j.dnarep.2009.10.003_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumoral activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.dnarep.2009.10.003_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15216540500079093","article-title":"The power and potential of doxorubicin-DNA adducts","volume":"57","author":"Cutts","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.dnarep.2009.10.003_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewitz","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib11","first-page":"115","article-title":"Evaluation of adriamycin induced DNA damage and repair in human and animals cells","volume":"59","author":"Chlopkiewicz","year":"2002","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.dnarep.2009.10.003_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(03)00287-7","article-title":"Mechanisms of human DNA repair: an update","volume":"193","author":"Christmann","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.dnarep.2009.10.003_bib13","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1128\/MCB.20.21.7980-7990.2000","article-title":"Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells","volume":"20","author":"de Silva","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/cr040478b","article-title":"Formation and repair of interstrand cross-links in DNA","volume":"106","author":"Noll","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.dnarep.2009.10.003_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.biochi.2003.10.017","article-title":"The eukaryotic nucleotide excision repair pathway","volume":"85","author":"Costa","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.dnarep.2009.10.003_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc1652","article-title":"Cancer in xeroderma pigmentosum and related disorders of DNA repair","volume":"5","author":"Cleaver","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.dnarep.2009.10.003_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1101\/gad.859501","article-title":"The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases","volume":"15","author":"Lehmann","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.dnarep.2009.10.003_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-9525(01)02280-6","article-title":"Trichothiodystrophy, a transcription syndrome","volume":"17","author":"Bergmann","year":"2001","journal-title":"Trends Genet."},{"key":"10.1016\/j.dnarep.2009.10.003_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6","article-title":"A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy","volume":"14","author":"Cleaver","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.dnarep.2009.10.003_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantification of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0921-8777(94)00043-6","article-title":"The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells","volume":"336","author":"Collins","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The comet assay for DNA damage and repair","volume":"26","author":"Collins","year":"2004","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2133.1992.tb14845.x","article-title":"Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair","volume":"127","author":"Sarasin","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0921-8777(96)00024-9","article-title":"Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene","volume":"364","author":"Quilliet","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1535-7163.621.3.5","article-title":"Topoisomerase poisons differentially activate DNA damage checkpoint through ataxia-telangiectasia mutated-dependent and independent mechanisms","volume":"3","author":"Siu","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.dnarep.2009.10.003_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2006.05.005","article-title":"Adriamycin-induced myocardial toxicity: new solutions for an old problem?","volume":"117","author":"Outomuro","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mrfmmm.2007.09.005","article-title":"DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair","volume":"638","author":"Spencer","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.cgt.7700797","article-title":"Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus","volume":"12","author":"Armelini","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.dnarep.2009.10.003_bib29","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","article-title":"Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death","volume":"66","author":"Swift","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib30","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bcp.2007.03.022","article-title":"Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin","volume":"73","author":"Gajewski","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib31","doi-asserted-by":"crossref","first-page":"H1273","DOI":"10.1152\/ajpheart.00738.2005","article-title":"DNA damage is an early event in doxorubicin-induced cardiac myocyte death","volume":"291","author":"L\u2019Ecuyer","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib32","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-strand breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2009.10.003_bib33","first-page":"4347","article-title":"Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks","volume":"63","author":"Ban\u00e1th","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2009.10.003_bib34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4161\/cc.5.10.2799","article-title":"The loss of \u03b3H2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage","volume":"5","author":"Bouquet","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.dnarep.2009.10.003_bib35","doi-asserted-by":"crossref","first-page":"53272","DOI":"10.1074\/jbc.M406879200","article-title":"Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species","volume":"279","author":"Kurz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2009.10.003_bib36","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1128\/MCB.25.18.8368-8378.2005","article-title":"Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome","volume":"25","author":"Theron","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib37","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/jm970237e","article-title":"Doxoform and daunoform: anthracycline\u2013formaldehyde conjugates toxic to resistant tumor cells","volume":"402","author":"Fenick","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.dnarep.2009.10.003_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1021\/tx990008q","article-title":"Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines","volume":"12","author":"Taajes","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.dnarep.2009.10.003_bib39","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkn439","article-title":"Detection of adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations","volume":"36","author":"Coldwell","year":"2008","journal-title":"Nucleic Acids Res."}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786409002778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786409002778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:00:33Z","timestamp":1685203233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786409002778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1568786409002778"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2009.10.003","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}